Why Do People With Down Syndrome Have a Shorter Lifespan?

People with Down syndrome have a shorter lifespan because the extra copy of chromosome 21 affects nearly every organ system, creating overlapping vulnerabilities that compound over a lifetime. Congenital heart defects, a profoundly altered immune system, a near-universal predisposition to early Alzheimer’s disease, and accelerated cellular aging all contribute. The good news is that life expectancy has improved enormously, rising from about 12 years in the late 1940s to roughly 60 years today, driven largely by advances in cardiac surgery and infection management.

Congenital Heart Disease Is the Single Biggest Early Threat

About half of all babies born with Down syndrome have a congenital heart defect, most commonly atrioventricular septal defects, ventricular septal defects, or tetralogy of Fallot. Before the era of open-heart surgery, many of these children did not survive infancy. That alone explains a large portion of the historically dismal life expectancy figures. Today, surgical repair is routine, and mortality rates after cardiac surgery in children with Down syndrome are comparable to those in children without the condition.¹ A national analysis of surgical outcomes found that while mortality was not significantly different between the two groups, children with Down syndrome did have longer hospital stays and higher rates of postoperative respiratory and infectious complications.²

When heart defects go unrepaired, the consequences can be devastating. A condition called Eisenmenger syndrome, where blood pressure in the lungs rises irreversibly because of a long-standing defect, used to develop in over half of people with Down syndrome born in the 1950s and 1960s. Thanks to earlier surgical intervention, that rate dropped to under 1% for those born after 2000. People who did develop Eisenmenger syndrome had dramatically worse survival compared to those who did not.³ The shift toward repairing hearts in the first year of life is one of the clearest reasons life expectancy has climbed so steeply.

An Immune System Wired Differently From Birth

The immune system in Down syndrome is not simply weaker. It is fundamentally rewired. Chromosome 21 carries four of the six genes that encode receptors for interferons, the signaling proteins the body uses to coordinate immune defense and inflammation. Having three copies of chromosome 21 means having extra copies of these receptor genes, which leads to a state researchers describe as a mild interferonopathy: the immune system behaves as though it is under constant low-grade inflammatory activation.⁴

Deep mapping of immune cells in adults with Down syndrome using advanced techniques has confirmed this picture. Every major immune cell lineage shows heightened sensitivity to interferon signaling, and the overall pattern resembles chronic inflammation.⁵ This has two consequences that cut in opposite directions. The chronic inflammatory state raises the risk of autoimmune conditions like thyroid disease and celiac disease, which are common in Down syndrome. At the same time, the altered immune landscape appears to offer some protection against certain cancers, a paradox discussed later in this article.

Respiratory Infections Hit Harder and More Often

The immune dysregulation, combined with anatomical features like a smaller airway, low muscle tone, and a tendency toward swallowing difficulties, means respiratory infections are one of the leading causes of hospitalization and death in people with Down syndrome at every age. In a large U.S. study, the rate of pneumonia was roughly five times higher in people with Down syndrome compared to matched controls. Those who developed pneumonia were about three times as likely to be hospitalized and more than three times as likely to end up in intensive care. One-year mortality after a first episode of pneumonia was also significantly higher.⁶

Children with Down syndrome are particularly vulnerable. Pneumonia causes hospitalization at about four times the rate seen in other children, and respiratory infections overall carry a higher likelihood of requiring intensive care and mechanical ventilation.⁷ Even common viral infections that most children weather without incident can escalate quickly in a child with Down syndrome, partly because of the immune differences and partly because their airways are structurally smaller and more prone to obstruction.

Obstructive Sleep Apnea and Airway Complications

Obstructive sleep apnea is extremely common in Down syndrome, driven by the same factors that increase respiratory vulnerability: a relatively small midface, enlarged tonsils and adenoids, low muscle tone in the throat, and higher rates of obesity. When present, the apnea tends to be more severe than in the general population.⁸ Untreated sleep apnea does not just cause poor sleep. Over years, it stresses the heart and lungs, contributes to pulmonary hypertension, and worsens cognitive function. In a population already at high risk for heart disease and dementia, the cumulative effect of chronic oxygen deprivation during sleep is a serious lifespan issue that is often underdiagnosed because the signs overlap with other features of Down syndrome, like daytime sleepiness and behavioral changes.

Swallowing difficulties and airway anomalies add to the burden. Dysphagia raises the risk of aspiration, where food or liquid enters the lungs instead of the stomach, which can trigger aspiration pneumonia on top of the already elevated pneumonia risk.⁹

Alzheimer’s Disease Begins Decades Early

If heart disease is the biggest threat in childhood, Alzheimer’s disease is the biggest threat in adulthood. The gene for amyloid precursor protein, the molecule that produces the amyloid plaques found in Alzheimer’s disease, sits on chromosome 21. Having three copies means overproducing amyloid from birth. By their 40s, nearly all people with Down syndrome show the brain pathology of Alzheimer’s disease, though not all develop clinical symptoms at the same pace.¹⁰ Those over 45 are significantly more likely to develop dementia, and once dementia sets in, the disease progresses with complications that directly threaten survival.¹¹

Seizures are one of those complications, and their relationship to dementia in Down syndrome is striking. Up to 84% of people with Down syndrome who develop dementia also develop seizures.¹¹ New-onset epilepsy tends to appear early in the course of dementia, sometimes as one of the first noticeable signs.¹² Seizures in this context are not just a symptom. They accelerate cognitive decline and functional loss, making it harder for people to eat, communicate, and care for themselves, all of which hasten decline.¹³

Accelerated Aging at the Cellular Level

Beyond any single organ system, the extra chromosome appears to speed up biological aging itself. One mechanism involves superoxide dismutase 1 (SOD1), an enzyme encoded on chromosome 21. With three copies producing excess enzyme, cells generate more hydrogen peroxide, a reactive molecule that damages DNA, proteins, and cell membranes. Studies of immune cells from people with Down syndrome show elevated markers of oxidative damage, including lipid peroxidation.¹⁴

Mitochondria, the structures inside cells that produce energy, are also affected. Research points to disrupted energy metabolism, increased oxidative stress within mitochondria, and impaired quality-control systems that normally clear out damaged mitochondria. These mitochondrial problems are thought to be central to the accelerated brain aging seen in Down syndrome and to contribute to the early onset of Alzheimer’s pathology.¹⁵ The upshot is that cells throughout the body in Down syndrome are aging faster than the calendar would suggest, wearing down tissues and organs on a compressed timeline.

Leukemia Risk and a Surprising Cancer Paradox

Children with Down syndrome face a significantly higher risk of acute leukemia compared to the general pediatric population.¹⁶ The risk is especially elevated for two specific types: acute megakaryoblastic leukemia and acute lymphoblastic leukemia. A precursor condition called transient myeloproliferative disorder, driven by a mutation in a gene called GATA1, affects up to 30% of newborns with Down syndrome. It usually resolves on its own, but about a quarter of affected infants later go on to develop full leukemia.¹⁷

Here is where the cancer picture gets genuinely interesting. While blood cancers are elevated, the risk of most solid tumors is actually lower in people with Down syndrome. A population-based study found significantly decreased risks of breast, prostate, lung, colorectal, and gynecological cancers, as well as melanoma.¹⁸ The reasons are still being worked out, but the same interferon hypersensitivity that causes immune dysregulation may also enhance immune surveillance against solid tumors. An additional copy of certain tumor-suppressor genes on chromosome 21 could also play a role. Despite this protective effect against common adult cancers, it does not offset the cumulative impact of the other health challenges, and childhood leukemia remains a significant early-life risk.

Gastrointestinal Defects in Infancy

About 7% of infants with Down syndrome are born with a major gastrointestinal malformation, most commonly duodenal atresia or stenosis, where the first part of the small intestine is blocked or narrowed.¹⁹ Hirschsprung disease, where nerve cells are missing from part of the colon, and anal atresia are also more frequent. These conditions require surgical repair in the newborn period, and when they co-occur with a heart defect, the combined burden carries a very high mortality rate.²⁰

Long-term outcomes after gastrointestinal surgery are also less favorable. One study of congenital duodenal obstruction found that early survival rates were similar between children with and without Down syndrome, but long-term overall survival was significantly worse in the Down syndrome group, with more early postoperative complications as well.²¹ The explanation likely lies not in the gut surgery itself but in the other conditions these children carry simultaneously, particularly heart defects and immune vulnerability.

Racial and Ethnic Disparities Widen the Gap

The lifespan gap in Down syndrome is not the same for everyone. Research on adults with intellectual and developmental disabilities in the United States has found a pattern of racial and ethnic inequality that looks different from the pattern in the general population. Among adults without intellectual disability, age at death varies in a roughly graded way across racial and ethnic groups. Among adults with intellectual disability, the pattern is more sharply split: White adults have the highest age at death, while all racial and ethnic minority groups have lower and similar ages at death.²² This suggests that the barriers minorities face in accessing high-quality, coordinated healthcare are amplified when combined with the medical complexity of conditions like Down syndrome.

The transition from pediatric to adult healthcare is a recognized weak point. Young adults with Down syndrome are vulnerable to delayed, fragmented, and poorly coordinated care as they age out of pediatric systems, which can lead to missed screenings and undertreated conditions during a period when proactive management is critical.²³ Until recently, there were no clinical guidelines specifically for the care of adults with Down syndrome, despite the unique combination of conditions they face. Average life expectancy rose from 25 years in 1983 to 60 years by 2020, but the healthcare system’s readiness to care for this aging population has lagged behind.²⁴

Down Syndrome Regression Disorder

A condition that has only recently gained wider recognition is Down syndrome regression disorder, or DSRD, which typically strikes adolescents and young adults. It involves a sudden loss of language, daily living skills, and autonomy, along with behavioral symptoms that can include depression, psychosis, or catatonia.²⁵ Because it involves cognitive and functional decline, it is sometimes confused with early Alzheimer’s disease. But research measuring Alzheimer’s-associated biomarkers in young people with DSRD has found no evidence of elevated Alzheimer’s pathology, supporting DSRD as a distinct condition.²⁶ While DSRD is not a direct cause of death, the rapid functional decline can lead to severe complications including inability to eat or communicate, and misdiagnosis can delay appropriate treatment. The existence of DSRD underscores how much the medical community is still learning about the trajectory of health in Down syndrome beyond the well-known cardiac and dementia risks.

Experimental Approaches Targeting Chromosome 21 Genes

Much of the damage described above traces back to overexpression of specific genes on the extra chromosome. One gene that has received significant attention is DYRK1A, which is overproduced in Down syndrome and has been linked to cognitive impairment and abnormal brain development. Researchers have explored reducing DYRK1A activity as a therapeutic strategy, with some promising results in mouse models and early human trials using a compound found in green tea called epigallocatechin gallate. A newer approach involves antisense oligonucleotides, synthetic molecules designed to selectively turn down the expression of a specific gene at the genetic level, potentially offering a more precise way to counteract the effects of DYRK1A overproduction.²⁷ These approaches are still experimental, but they represent a shift from treating the downstream consequences of trisomy 21 to trying to address the root genetic imbalance. Whether such strategies could meaningfully extend lifespan is unknown, but reducing the burden of cognitive decline or immune dysregulation could have wide-reaching effects on quality of life and health outcomes.

Cervical Spine Instability

A less-discussed but clinically important concern is instability of the upper cervical spine. The ligaments that hold the top two vertebrae together are looser in people with Down syndrome because of the generalized ligament laxity that comes with the condition. This instability, called atlantoaxial instability, is detectable on X-ray in a substantial minority, though symptomatic spinal cord compression occurs in only about 1 to 2% of individuals.²⁸ When it does become symptomatic, spinal cord compression can cause weakness, changes in gait, loss of bladder control, and in severe cases, paralysis. This is a risk that requires screening and awareness rather than a major driver of mortality, but it illustrates how the extra chromosome reaches into unexpected corners of health, affecting connective tissue as well as the brain, immune system, and heart.